CRS0540 Gram-positives
Publication of Data on the Novel Antibiotic CRS0540
Announcement Regarding CRS0540: Crestone, Inc. and Praedicare Inc. Announce the Publication of...
Read More
Presentations at the 2022 ASM Microbe
2022 ASM Microbe Presentation Details Oral Session: In vivo Pharmacodynamic Evaluation of CRS0540...
Read More
Crestone, Inc. joins the Antimicrobials Working Group
June 8, 2021 – Announcement: Crestone, Inc. joins the Antimicrobials Working Group to Combat...
Read More
Funding Secured for Development Through Phase 1: CRS0540
July 1, 2020 – Announcement: Crestone, Inc. Secures NIH Funding for Development Through...
Read More
Presentation at the 29th ECCMID in Amsterdam, Netherlands
Presentation Overview Crestone, Inc. presents at the 29th ECCMID in Amsterdam, Netherlands. Oral...
Read More
Presentation at the ESCMID/ASM Conference
ESCMID/ASM Conference Presentation Details Crestone presents a poster at ESCMID/ASM Conference on...
Read More
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor, a team member, or a participant in our ongoing clinical studies.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a team-oriented environment at one of the leading Colorado pharma companies.
Clinical Studies
Learn how you can become part of our ongoing clinical study to fight deadly GI tract infections.